Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Virginia Center for Reproductive Medicine
WARNING LETTER
•Virginia Center for Reproductive Medicine•June 12, 2013

Virginia Center for Reproductive Medicine – FDA Warning Letter, Jun 12, 2013

Record Details

The FDA conducted an inspection of Virginia Center for Reproductive Medicine from April to June 2013, documenting significant deviations from 21 CFR Part 1271 regulations for human cells, tissues, and cellular and tissue-based products (HCT/Ps).

Key violations include: 1. **Failure to determine donor ineligibility:** Donors with reactive screening tests for communicable diseases (e.g., HIV, HBc, HTLV-IIII) were not deemed ineligible, and their semen was still recovered. 2. **Failure to determine donor ineligibility based on risk factors:** Donors with risk factors (e.g., sex with other men, extensive residence in Europe during specific periods) were not determined ineligible. 3. **Improper labeling of HCT/Ps from ineligible donors:** HCT/Ps from donors with reactive tests or risk factors were not prominently labeled with "Biohazard" or appropriate warning statements. 4. **Failure to determine and document donor eligibility:** Eligibility determinations were not performed for several donors, or were made without reviewing complete screening/testing results. 5. **Failure to test for communicable diseases:** An anonymous oocyte donor was determined eligible and allowed to donate without required communicable disease testing. 6. **Failure to screen donors:** Several donors lacked documented medical history interviews or physical examinations. 7. **Inadequate summary of records:** Summaries accompanying H

Company
Virginia Center for Reproductive Medicine
Inspection date
June 12, 2013
Product type
Biologics
Office
Baltimore District Office
People
  • Evelyn Bonnin (District Director)
  • Rochelle B. Young
View Company Profile

ID · f6875b07-afbb-4788-85ab-d4e32218bd26

Violation Codes10
21 CFR 127142 U.S.C. 26421 CFR 1271.80(d)(1)21 CFR 1271.75(a)(1)21 CFR 1271.75(b)21 CFR 1271.75(c)21 CFR 1271.75(d)(1)21 CFR 1271.65(b)(2)21 CFR 1271.50(a)21 CFR 1271.85(a)

Full citation text and observation details available on the Dashboard.

Other documents for Virginia Center for Reproductive Medicine
  • 483 - 2023-09-20September 20, 2023
  • 483 - 2021-10-29October 29, 2021
  • WARNING_LETTER - 2019-02-25February 25, 2019
  • 483 - 2019-02-25February 25, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Virginia Center for Reproductive Medicine
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.